Modification of the Primary Tumor Microenvironment by Transforming Growth Factor α-Epidermal Growth Factor Receptor Signaling Promotes Metastasis in an Orthotopic Colon Cancer Model
- 31 July 2008
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 173 (1), 205-216
- https://doi.org/10.2353/ajpath.2008.071147
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- The Myofibroblast: One Function, Multiple OriginsThe American Journal of Pathology, 2007
- Decreased Macrophage Number and Activation Lead to Reduced Lymphatic Vessel Formation and Contribute to Impaired Diabetic Wound HealingThe American Journal of Pathology, 2007
- The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastasesBritish Journal of Cancer, 2007
- A Novel Mechanism of Resistance to Epidermal Growth Factor Receptor Antagonism In vivoCancer Research, 2007
- ERBB receptors and cancer: the complexity of targeted inhibitorsNature Reviews Cancer, 2005
- Systemic Therapy for Colorectal CancerNew England Journal of Medicine, 2005
- Phase II Trial of Cetuximab in Patients With Refractory Colorectal Cancer That Expresses the Epidermal Growth Factor ReceptorJournal of Clinical Oncology, 2004
- Focus on colon cancerCancer Cell, 2002
- Clinical relevance of transforming growth factor ?, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumorsHepatology, 1998
- Correlation of epidermal growth factor receptor and c-erbB2 oncogene product to known prognostic indicators of colorectal cancerSurgical Oncology, 1992